Marc Dechamps

CEO at Bioxodes

Speaker

Marc Dechamps is a biologist with extensive experience in the pharmaceutical industry dating back more than 35 years. During his career, he has worked for corporate pharma companies including GSK & ViiVHealthcare, building his expertise in market development for new products, including infectious diseases, immunological disorders, oncology, CNS disorders and vaccines. In 2016, Marc founded and became managing director of XMF consulting, a company which supports biotech and biopharma businesses with strategic advice and management leadership. He has also served as managing director of Delphi Genetics (CDMO) and interim CEO of eTheRNA Immunotherapies (a Belgian mRNA clinical stage biotech company). Marc is currently co-academic director for the newly created advanced masters in biotech & medtech ventures at the Solvay Brussels School of Economics & Management. He is also responsible for representing BioWin – the life sciences cluster of Wallonia – on the international stage - and serves as president of the board for the Council of European BioRegions (CEBR) and the investment group Investsud Tech.